Alpha psychiatryPub Date : 2026-10-14eCollection Date: 2026-10-01DOI: 10.31083/AP51147
Tuğba Aşkan, Birgül Özkan, Gülsüm Zuhal Kamış, Mustafa Uğurlu
{"title":"Short-Term Effectiveness of a Psychotherapeutic Intervention Model in Nursing for Ineffective Coping in GAD Outpatients: A Small-Sample Randomized Controlled Trial.","authors":"Tuğba Aşkan, Birgül Özkan, Gülsüm Zuhal Kamış, Mustafa Uğurlu","doi":"10.31083/AP51147","DOIUrl":"10.31083/AP51147","url":null,"abstract":"<p><strong>Background: </strong>Although nurse-delivered psychotherapeutic interventions have demonstrated benefits for individuals with anxiety disorders, no randomized controlled trial has evaluated the effectiveness of the Psychotherapeutic Intervention Model in Nursing for the nursing diagnosis of ineffective coping among psychiatric outpatients with generalized anxiety disorder (GAD). This study aimed to examine the short-term effectiveness of this model on the nursing-sensitive outcomes of coping and self-esteem.</p><p><strong>Methods: </strong>This single-blind randomized controlled trial was conducted among patients diagnosed with GAD. A total of 20 participants were randomized, of whom 17 completed the study. Seven of eight participants in the IG and eight of nine participants in the TAU group received pharmacotherapy, while participants in the IG additionally participated in a seven-week Psychotherapeutic Intervention Model in Nursing program. Data were collected at baseline (T0) and week 8 (T1) using information forms and the Nursing Outcomes Classification (NOC) Coping and Self-Esteem outcome measures. Statistical analyses included descriptive statistics, chi-square tests, independent-samples t tests, and repeated-measures general linear models. Statistical significance was set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>Significant time × group interactions were observed for both NOC Coping and Self-Esteem outcomes. Participants in the IG demonstrated significantly greater improvements over time than those in the TAU group in coping (T0: 42.87 ± 6.03, T1: 76.75 ± 5.34, <i>p</i> < 0.001) and self-esteem (T0: 57.25 ± 7.29, T1: 78.62 ± 6.14, <i>p</i> < 0.001). In the TAU group, no significant changes were observed in coping (T0: 45.11 ± 6.70, T1: 45.33 ± 8.96, <i>p</i> > 0.05) or self-esteem (T0: 59.44 ± 8.63, T1: 58.89 ± 10.11, <i>p</i> > 0.05).</p><p><strong>Conclusions: </strong>This study provides preliminary evidence supporting the short-term effectiveness of the Psychotherapeutic Intervention Model in Nursing in improving NOC Coping and Self-Esteem outcomes among psychiatric outpatients with GAD and a nursing diagnosis of ineffective coping. Larger, multicenter randomized controlled trials with longer follow-up periods are warranted to confirm these findings.</p><p><strong>Clinical trial registration: </strong>This study is registered on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT06076746 (registration number: NCT06076746).</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"51147"},"PeriodicalIF":2.9,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alpha psychiatryPub Date : 2026-10-14eCollection Date: 2026-10-01DOI: 10.31083/AP52716
Xinqi Wang, Fei Nie, Xi Zhang, Qiuping Tang, Chen Pan
{"title":"Effect of Adverse Childhood Experiences on Nonsuicidal Self-Injury in Adolescents With Mood Disorders.","authors":"Xinqi Wang, Fei Nie, Xi Zhang, Qiuping Tang, Chen Pan","doi":"10.31083/AP52716","DOIUrl":"10.31083/AP52716","url":null,"abstract":"<p><strong>Background: </strong>Nonsuicidal self-injury (NSSI) is a severe global health concern, particularly among adolescents, and is closely associated with adverse childhood experiences (ACEs). However, the underlying mechanisms by which ACEs are associated with NSSI remain largely unknown, although peer attachment and alexithymia have been identified as potentially relevant to this relationship. This observational study aimed to test a chain mediation model examining the indirect associations among ACEs, peer attachment, alexithymia, and NSSI in adolescents with mood disorders.</p><p><strong>Methods: </strong>A total of 363 adolescents with mood disorders were recruited from the outpatient clinical psychology department of a general hospital. Clinical interview tools and self-report questionnaires were used to evaluate patients' history of NSSI, ACEs, peer attachment, and alexithymia. Comparisons were made between groups of patients who did and did not meet the criteria for NSSI diagnosis, and peer attachment and alexithymia were evaluated for potential mediating effects.</p><p><strong>Results: </strong>In total, 203 (55.9%) patients were included in the NSSI group. In the chain mediation model, ACEs were directly associated with NSSI, with a significant effect size of 0.246 (95% confidence interval [CI]: 0.088, 0.404), accounting for 64.2% of the total effect. Peer attachment and alexithymia had a total indirect effect of 0.137 (95% CI: 0.079, 0.221), accounting for 35.8% of the total effect.</p><p><strong>Conclusions: </strong>In addition to reaffirming the direct association between ACEs and NSSI, this study provides novel insight into a chain of indirect associations linking peer attachment and alexithymia to the ACE-NSSI relationship.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"52716"},"PeriodicalIF":2.9,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alpha psychiatryPub Date : 2026-10-12eCollection Date: 2026-10-01DOI: 10.31083/AP47427
Charles Lai, Peter Bota, Jonathan Steve Shaw
{"title":"Unequal Access to Transcranial Magnetic Stimulation and Electroconvulsive Therapy for Treatment-Resistant Depression in the United States: Advancements in Therapies and Continued Disparities.","authors":"Charles Lai, Peter Bota, Jonathan Steve Shaw","doi":"10.31083/AP47427","DOIUrl":"10.31083/AP47427","url":null,"abstract":"","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"47427"},"PeriodicalIF":2.9,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alpha psychiatryPub Date : 2026-10-10eCollection Date: 2026-10-01DOI: 10.31083/AP52813
Qianqi Zhao, Junhe Zhou, Junjun Chen, Wenbin Fu
{"title":"Polysomnography Indicators Associated With Moderate Depression: A Cross-Sectional Study.","authors":"Qianqi Zhao, Junhe Zhou, Junjun Chen, Wenbin Fu","doi":"10.31083/AP52813","DOIUrl":"10.31083/AP52813","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to use polysomnography (PSG) and clinical rating scales to evaluate sleep quality, sleep characteristics, and their associations in patients with moderate depression.</p><p><strong>Methods: </strong>A total of 52 patients with moderate depression and 21 healthy controls were enrolled. All participants underwent PSG and were assessed using the Pittsburgh Sleep Quality Index (PSQI). Differences in clinical characteristics between the two groups were analyzed. Multivariate binary logistic regression analysis was performed to identify factors associated with moderate depression. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of PSG indicators for moderate depression.</p><p><strong>Results: </strong>Compared with healthy controls, patients with moderate depression exhibited significantly higher total PSQI scores and poorer objective sleep quality based on PSG measurements. Specifically, they had shorter total sleep time (TST), longer wake after sleep onset (WASO), lower sleep efficiency (SE), a higher percentage of wakefulness (W%), fewer rapid eye movement (REM) sleep cycles, and a higher apnea-hypopnea index (AHI) (all <i>p</i> < 0.05). Multivariate binary logistic regression analysis showed that each 1-point increase in the PSQI score was associated with a 6.66-fold increase in the odds of moderate depression (95% CI = 1.143-38.835, <i>p</i> = 0.035). The PSQI score showed excellent discriminative performance (AUC = 0.990, 95% CI: 0.974-1.000), whereas the univariate ROC results for age, ArI, REM cycle, and AHI should be interpreted cautiously as exploratory findings rather than evidence of independent predictive value.</p><p><strong>Conclusions: </strong>Patients with moderate depression exhibit poorer subjective and objective sleep quality than healthy individuals and demonstrate distinct polysomnographic characteristics.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"52813"},"PeriodicalIF":2.9,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuromodulation Therapies for Depression: Current Status and Future Directions.","authors":"Yuki Matsuda, Kenji Sakuma, Shun Igarashi, Daisuke Hayashi, Shinsuke Kito, Taro Kishi","doi":"10.31083/AP53313","DOIUrl":"10.31083/AP53313","url":null,"abstract":"<p><p>Major depressive disorder is a leading cause of disability worldwide, and many patients fail to achieve sustained remission with first-line pharmacotherapy or psychotherapy. This unmet need has traditionally been framed as treatment-resistant depression (TRD), defined by an inadequate response to antidepressant treatment. Within this context, neuromodulation has assumed an increasingly important role by providing mechanistically distinct interventions when medication-based approaches are insufficient, poorly tolerated, or too slow. In this expert opinion article, we present a targeted, clinically oriented review of two established neuromodulation therapies for depression, electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), encompassing conventional repetitive TMS (rTMS), deep TMS, and theta-burst stimulation (TBS), as well as magnetic seizure therapy (MST), the most clinically advanced investigational convulsive modality. ECT remains the benchmark treatment for severe, urgent, psychotic, or otherwise refractory depression due to its rapid and robust efficacy, although its use is limited by anesthesia requirements, cognitive adverse effects, and associated stigma. TMS has the strongest evidence base among nonconvulsive neuromodulation treatments, with pivotal sham-controlled multicenter trials supporting conventional rTMS and deep TMS, while TBS protocols are improving feasibility, access, and scalability. MST is conceptually appealing as a more focal convulsive treatment designed to preserve antidepressant efficacy while reducing cognitive burden; recent Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST) data have strengthened its evidence base, but its routine clinical role remains to be defined through regulatory approval, durability data, and implementation evidence. We argue that future progress will depend not only on the development of new stimulation protocols but also on improved clinical sequencing, patient selection, and maintenance strategies that help sustain acute gains. The concept of difficult-to-treat depression (DTD) broadens the clinical framework beyond antidepressant nonresponse to include persistent burden, partial response, tolerability constraints, functional impairment, and patient-centered goals. This perspective may inform earlier and more strategic use of neuromodulation, although most randomized controlled trials remain focused on TRD. Further studies are needed to determine whether DTD-based approaches improve real-world outcomes. Advances are likely to arise from integrating protocol refinement, individualized targeting, scalable home-based approaches, depression-relevant extensions such as bipolar depression, and durable maintenance strategies rather than identifying a single universally superior modality.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"53313"},"PeriodicalIF":2.9,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alpha psychiatryPub Date : 2026-09-10eCollection Date: 2026-10-01DOI: 10.31083/AP46465
Ying Li, Jiali Liu, Xintong Wang, Guifang Chen
{"title":"Efficacy and Neural Mechanisms of Eye Movement Desensitization and Reprocessing (EMDR) for Depression: A Systematic Review and Qualitative Synthesis.","authors":"Ying Li, Jiali Liu, Xintong Wang, Guifang Chen","doi":"10.31083/AP46465","DOIUrl":"10.31083/AP46465","url":null,"abstract":"<p><strong>Background: </strong>Depression is a psychiatric disorder characterized by mood disturbances and cognitive impairment. Existing treatments, such as pharmacotherapy and cognitive-behavioral therapy (CBT), often present limitations, including delayed onset of efficacy and low adherence. Eye Movement Desensitization and Reprocessing (EMDR), a psychotherapy originally developed for post-traumatic stress disorder (PTSD), has shown potential in the treatment of depression.</p><p><strong>Methods: </strong>This systematic review synthesized evidence from 27 studies (14 randomized controlled trials, 10 single-arm studies, and three controlled studies) published between January 1990 and December 2024, integrating both behavioral outcomes and findings on neural mechanisms. Literature searches were conducted in PubMed, Web of Science, and ScienceDirect.</p><p><strong>Results: </strong>The findings indicate that EMDR demonstrates potential efficacy in alleviating depressive symptoms. The included studies involved diverse populations, including individuals with major depressive disorder, comorbid conditions, and trauma exposure, suggesting potential applicability across a range of clinical contexts. Preliminary neurobiological evidence has explored possible mechanisms involving modulation of prefrontal-limbic circuits and the integration of traumatic memories, providing initial insights into its therapeutic effects.</p><p><strong>Conclusions: </strong>Current evidence supports EMDR as a promising intervention for depression. However, further large-scale, high-quality studies are required to confirm its generalizability, identify optimal target populations, and clarify its underlying neurobiological mechanisms.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"46465"},"PeriodicalIF":2.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alpha psychiatryPub Date : 2026-09-10eCollection Date: 2026-10-01DOI: 10.31083/AP50801
Xiaochao Yu, Zhiqiu He, Kewu Wang, Huina Tang, Yunrong Lu, Jibo Hu
{"title":"Neuroimaging Studies of Bipolar Disorder With Suicide Attempts: A Systematic Review.","authors":"Xiaochao Yu, Zhiqiu He, Kewu Wang, Huina Tang, Yunrong Lu, Jibo Hu","doi":"10.31083/AP50801","DOIUrl":"10.31083/AP50801","url":null,"abstract":"<p><strong>Background: </strong>Suicide attempts (SA) represent a high-risk indicator for subsequent suicidal behavior in patients with bipolar disorder (BD). However their underlying neurobiological mechanisms remain incompletely understood.</p><p><strong>Method: </strong>This systematic review synthesized neuroimaging findings from the PubMed and Web of Science databases (January 1990 to April 2026) to elucidate the structural and functional brain alterations associated with SA in BD.</p><p><strong>Results: </strong>Structural magnetic resonance imaging (MRI) studies revealed reductions in prefrontal-limbic gray matter, alterations in the corpus callosum, and inconsistent findings regarding cerebellar volume. Diffusion tensor imaging (DTI) demonstrated microstructural disconnection in the uncinate fasciculus, inferior fronto-occipital fasciculus, cingulum bundle, forceps minor, and the corpus callosum, with reduced fractional anisotropy correlating with impulsivity and suicidal intent. Functional MRI identified a multilevel pattern of dysfunction, characterized by limbic and paralimbic hyperactivity (including the anterior cingulate cortex, insula, and temporal regions) alongside prefrontal hypoactivity. Network dysregulation was characterized by hyperconnectivity within the default mode network and hypoconnectivity within the salience and executive control networks, as well as altered amygdala-prefrontal and frontotemporal connectivity. Whole-brain dynamic analyses further demonstrated prolonged dwell time in a maladaptive brain state.</p><p><strong>Conclusions: </strong>Convergent multimodal evidence supports an integrated model in which structural and functional vulnerabilities disrupt emotion regulation and behavioral control, thereby facilitating the transition from suicidal ideation to suicidal behavior. Neuroimaging findings may represent potential candidate biomarkers; however, prospective validation is required before these markers can inform risk stratification or targeted interventions for suicide prevention in BD.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"50801"},"PeriodicalIF":2.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alpha psychiatryPub Date : 2026-09-09eCollection Date: 2026-10-01DOI: 10.31083/AP51154
Wenfeng Zhen, Han Wu, Shuo Lin, Dandi Zhu, Siyuan Lian, Li Ren, Yilang Tang, Yanping Ren, Xin Ma
{"title":"Changes in Symptoms and Cognition Following Electroconvulsive Therapy in Late-Life Depression: Analyses Stratified by Baseline Anxiety Levels.","authors":"Wenfeng Zhen, Han Wu, Shuo Lin, Dandi Zhu, Siyuan Lian, Li Ren, Yilang Tang, Yanping Ren, Xin Ma","doi":"10.31083/AP51154","DOIUrl":"10.31083/AP51154","url":null,"abstract":"<p><strong>Background: </strong>Late-life depression (LLD) is commonly complicated by comorbid anxiety. However, whether the severity of baseline anxiety is associated with differential symptomatic and cognitive outcomes following electroconvulsive therapy (ECT) in LLD remains unclear, particularly with respect to cognitive safety in high-anxiety older patients.</p><p><strong>Methods: </strong>This prospective self-controlled pre-post study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Ninety-three patients aged ≥60 years with LLD received an acute course of ECT and were stratified into mild-to-moderate anxiety (Hamilton Anxiety Rating Scale [HAMA] score 14-28) and severe anxiety (HAMA score ≥29) groups according to established HAMA severity cutoffs. Depressive symptoms (24-item Hamilton Depression Rating Scale [HAMD-24]), anxiety symptoms (HAMA-14), and cognitive performance (Montreal Cognitive Assessment [MoCA] and Repeatable Battery for the Assessment of Neuropsychological Status [RBANS]) were assessed at baseline and after completion of ECT treatment. Linear mixed-effects models (LMMs) with participant-level random intercepts were used to examine differential treatment trajectories while adjusting for demographic characteristics and baseline symptom severity. Hierarchical regression analyses were performed to determine whether improvement in anxiety symptoms (ΔHAMA) predicted antidepressant response (ΔHAMD) and cognitive change (ΔMoCA).</p><p><strong>Results: </strong>Both groups demonstrated significant reductions in depressive and anxiety symptoms following ECT. Baseline HAMA and HAMD-24 scores were not significantly correlated (<i>r</i> = 0.12, <i>p</i> = 0.24), suggesting that anxiety and depressive symptom severity represented distinct constructs. After multivariable adjustment, the severe anxiety group showed an antidepressant response comparable to that of the mild-to-moderate anxiety group (HAMD-24 total score interaction, <i>p</i> = 0.155), but exhibited significantly greater improvements in HAMA total and subdomain scores (all <i>p</i> < 0.01), as well as in the HAMD anxiety/somatization and retardation factors (both <i>p</i> < 0.05). Global cognitive performance remained stable across groups, with no significant differences observed in MoCA or RBANS total scores (both <i>p</i> > 0.60). Improvement in the RBANS attention domain was the only cognitive outcome that differed significantly between groups, favoring the severe anxiety group (<i>p</i> = 0.004). Greater improvement in anxiety symptoms predicted a stronger antidepressant response (<i>β</i> = 0.31, <i>p</i> < 0.001); however, this association did not differ between anxiety severity groups (<i>p</i> = 0.316) and was not related to cognitive change (<i>p</i> = 0.443).</p><p><strong>Conclusions: </strong>In patients with LLD, more severe baseline anxiety does not predict a greater overall antidepres","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"51154"},"PeriodicalIF":2.9,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alpha psychiatryPub Date : 2026-09-07eCollection Date: 2026-10-01DOI: 10.31083/AP52507
Lili Wu, Xing Wei, Mengyun Zhang, Chengbing Huang, Wenjie Shi
{"title":"Correlation Analysis of Peripheral Blood Inflammatory Cell Markers With Obesity in Chronic Schizophrenia Patients.","authors":"Lili Wu, Xing Wei, Mengyun Zhang, Chengbing Huang, Wenjie Shi","doi":"10.31083/AP52507","DOIUrl":"10.31083/AP52507","url":null,"abstract":"<p><strong>Background: </strong>This study investigated the association between obesity and peripheral blood inflammatory cell markers, namely the systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR), in patients with chronic schizophrenia.</p><p><strong>Methods: </strong>A total of 220 hospitalized patients with schizophrenia were enrolled. Obesity was assessed using body mass index (BMI), calculated according to standardized procedures. Participants were categorized into an obesity group (n = 86; BMI ≥28.0 kg/m<sup>2</sup>) and a non-obesity group (n = 134; BMI 18.5-24.0 kg/m<sup>2</sup>). Levels of SII, NLR, PLR, neutrophil count, lymphocyte count, and platelet count were measured and compared between the two groups. Correlations between SII, NLR, PLR, and obesity were subsequently analyzed.</p><p><strong>Results: </strong>Compared with the non-obesity group, the obesity group exhibited significantly higher SII values, lymphocyte counts, platelet counts, and suicide risk scores. BMI was positively correlated with SII. In addition, NLR was positively correlated with suicide risk scores.</p><p><strong>Conclusions: </strong>Patients with chronic schizophrenia and obesity exhibit elevated SII, lymphocyte counts, platelet counts, and suicide risk. SII may serve as a novel peripheral inflammatory marker for predicting obesity in this patient population.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"27 5","pages":"52507"},"PeriodicalIF":2.9,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}